Table 4.
Regimens used in first-line chemotherapy according to geographic distribution
| N (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regimen | All | Taipei | Northern | Central | Southern | KPE | ||||||
| Total | 17,443 | (100.0) | 6,494 | (37.2)* | 1,910 | (10.9)* | 3,434 | (19.7)* | 2,888 | (16.6)* | 2,717 | (15.6)* |
| Platinum with | 11,678 | (66.9) | 4,147 | (63.9) | 1,372 | (71.8) | 2,234 | (65.1) | 2,008 | (69.5) | 1,917 | ( 70.6) |
| gemcitabine | 5,893 | (33.8) | 1,936 | (29.8) | 503 | (26.3) | 1,485 | (43.2) | 1067 | (36.9) | 902 | ( 33.2) |
| docetaxel | 2,027 | (11.6) | 690 | (10.6) | 408 | (21.4) | 262 | (7.6) | 402 | (13.9) | 265 | (9.8) |
| vinorelbine | 1,653 | (9.5) | 552 | (8.5) | 232 | (12.1) | 136 | (4.0) | 287 | (9.9) | 446 | (16.4) |
| paclitaxel | 1,232 | (7.1) | 567 | (8.7) | 152 | (8.0) | 207 | (6.0) | 112 | (3.9) | 194 | (7.1) |
| pemetrexed | 270 | (1.5) | 137 | (2.1) | 19 | (1.0) | 72 | (2.1) | 24 | (0.8) | 18 | (0.7) |
| etoposide | 141 | (0.8) | 59 | (0.9) | 12 | (0.6) | 14 | (0.4) | 26 | (0.9) | 30 | (1.1) |
| others | 462 | (2.6) | 206 | (3.2) | 46 | (2.4) | 58 | (1.7) | 90 | (3.1) | 62 | (2.3) |
| Single agent | 5,144 | (29.5) | 2,013 | (31.0) | 506 | (26.5) | 1,072 | (31.2) | 813 | (28.2) | 740 | (27.2) |
| vinorelbine | 2,275 | (13.0) | 1,021 | (15.7) | 228 | (11.9) | 295 | (8.6) | 434 | (15.0) | 297 | (10.9) |
| gemcitabine | 1,692 | (9.7) | 557 | (8.6) | 139 | (7.3) | 503 | (14.6) | 213 | (7.4) | 280 | (10.3) |
| docetaxel | 584 | (3.3) | 216 | (3.3) | 56 | (2.9) | 157 | (4.6) | 56 | (1.9) | 99 | (3.6) |
| paclitaxel | 299 | (1.7) | 115 | (1.8) | 65 | (3.4) | 48 | (1.4) | 34 | (1.2) | 37 | (1.4) |
| tegafur, combinations | 294 | (1.7) | 104 | (1.6) | 18 | (0.9) | 69 | (2.0) | 76 | (2.6) | 27 | (1.0) |
| Others | 621 | (3.6) | 334 | (5.1) | 32 | (1.7) | 128 | (3.7) | 67 | (2.3) | 60 | (2.2) |
Abbreviations: KPE = Kaohsiung, Ping-Tung, and Eastern
*: This percentage was based on total 17,443 patients